# Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation

> **NCT03182413** · PHASE1 · COMPLETED · sponsor: **Theranexus** · enrollment: 20 (actual)

## Conditions studied

- Sleep Deprivation

## Interventions

- **DRUG:** Placebo
- **DRUG:** Modafinil
- **DRUG:** THN102

## Key facts

- **NCT ID:** NCT03182413
- **Lead sponsor:** Theranexus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2015-12
- **Final completion:** 2016-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03182413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03182413, "Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03182413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*